Загрузка...
Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review
Peripheral T-cell lymphoma (PTCL) is a disease with poor prognosis and limited treatment options. Recent advances in cancer biology suggest that PTCL may be characterized by gross epigenetic dysregulation, which may help explain its sensitivity to histone deacetylase (HDAC) inhibitors. HDAC inhibito...
Сохранить в:
| Опубликовано в: : | Ther Adv Hematol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530372/ https://ncbi.nlm.nih.gov/pubmed/26288714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620715592567 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|